Fig. 3From: Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trialDiagram of the POP trial study design over a total of 22 h including blood sampling times and recording of adverse events. ECG electrocardiogram, NAC N-acetylcysteineBack to article page